Comprehensive Management of Chronic Obstructive Pulmonary Disease (COPD)

Introduction to COPD Management

The American Thoracic Society recommends a comprehensive treatment plan for COPD, including pharmacologic therapy based on GOLD classification, pulmonary rehabilitation, smoking cessation, vaccinations, oxygen therapy when indicated, and self-management education to reduce mortality and improve quality of life 1, 2

For COPD patients with low symptoms and low risk (GOLD Group A), the American College of Chest Physicians recommends starting with a short-acting bronchodilator (SABA or SAMA) as needed 1, 2
For COPD patients with high symptoms and low risk (GOLD Group B), the European Respiratory Society recommends starting with a long-acting bronchodilator (LABA or LAMA) 2
For COPD patients with low symptoms and high risk (GOLD Group C), the American Thoracic Society recommends starting with a LAMA 2
For COPD patients with high symptoms and high risk (GOLD Group D), the Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommends starting with LAMA + LABA 1, 2

The American College of Chest Physicians recommends offering pulmonary rehabilitation to patients with high symptom burden and risk of exacerbations (GOLD groups B, C, and D) 1, 2
The European Respiratory Society recommends initiating rehabilitation within 3 weeks after hospital discharge, but not during hospitalization 3
Exercise training should include a combination of constant load or interval training with strength training, as recommended by the American Thoracic Society 1, 2

The American Thoracic Society recommends long-term oxygen therapy (LTOT) for stable patients who have PaO₂ ≤ 55 mmHg or SaO₂ ≤ 88%, with or without hypercapnia, confirmed twice over 3 weeks 1, 2
LTOT improves survival in hypoxemic patients and is the only treatment besides smoking cessation shown to modify survival rates in severe cases, according to the European Respiratory Journal 5

The American College of Chest Physicians recommends an educational program that includes smoking cessation strategies, basic information about COPD, proper use of respiratory medications and inhalation devices, strategies to minimize dyspnea, and advice about when to seek help 1, 2

The European Respiratory Society recommends nutritional supplementation for malnourished patients with COPD 1, 2
Weight loss and muscle wasting contribute significantly to morbidity and disability, as reported by the European Respiratory Journal 5

The American Thoracic Society recommends annual influenza vaccination for all patients with COPD 1, 2
The Centers for Disease Control and Prevention (CDC) recommends pneumococcal vaccinations, including PCV13 and PPSV23, for all patients older than 65 years 2

The American College of Chest Physicians recommends increasing bronchodilator therapy and prescribing antibiotics if two or more of the following are present: increased breathlessness, increased sputum volume, or development of purulent sputum 6
The European Respiratory Society recommends considering oral corticosteroids for significant symptom increase 6

The American Thoracic Society recommends considering non-invasive ventilation (NIV) for patients with pronounced daytime hypercapnia and recent hospitalization 1, 2
The American College of Chest Physicians recommends lung volume reduction (surgical or bronchoscopic) for selected patients with emphysema and significant hyperinflation refractory to medical care 1, 2

The American College of Chest Physicians recommends regular follow-up assessments, including measurement of FEV₁, reassessment of inhaler technique, review of patient's understanding of treatment regimen, evaluation of patient's ability to cope with the disease, and assessment for need of LTOT or home nebulizer usage in severe COPD 6